banner
CMCT-FA modified doxorubicin nanoliposomes
Inquiry

Cat. No.: X26-05-ZQ1664

CMCT-FA modified doxorubicin nanoliposomes

Synonym: CMCT-FA doxorubicin nanoliposomes; CMCT-FA modified DOX NLs; CMCT-FA functionalized doxorubicin nanoliposomes

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This highly specialized system comprises carboxymethyl chitosan triptolide conjugate and folate co-modified doxorubicin nanoliposomes (CMCT-FA modified doxorubicin nanoliposomes). The structural matrix incorporates hydrophilic doxorubicin hydrochloride within the central aqueous core of a high-purity phospholipid bilayer shell via an ammonium sulfate gradient, while the external boundary is co-functionalized with folate (FA) targeting ligands and a carboxymethyl chitosan triptolide (CMCT) polymer conjugate backbone. This dual surface modification alters the surface charge topography, membrane elasticity, and introduces a dense protective polysaccharide shield. The surrounding lipid shell isolates the active core while presenting the folate and modified chitosan array for advanced surface-binding evaluations.
Source
Custom synthesis
Functional Group
Carboxymethyl chitosan; Folate; Doxorubicin
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.